查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1974049

mRNA合成与製造市场分析及预测（至2035年）：依类型、产品、服务、技术、应用、製程、最终用户、组件及阶段划分

mRNA Synthesis and Manufacturing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, Process, End User, Component, Stage
出版日期: | 出版商: Global Insight Services | 英文 318 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计mRNA合成与生产市场将从2024年的14亿美元成长到2034年的82亿美元，复合年增长率约为19.3%。 mRNA合成与生产市场涵盖用于治疗和疫苗应用的传讯RNA（mRNA）的生产。生物技术的进步推动了该市场的发展，使得基于mRNA的解决方案能够快速开发和扩充性生产。关键领域包括合成技术、纯化製程和品管，以确保其有效性和安全性。个人化医疗和感染疾病控制的进步正在推动市场成长，促使企业对研发和基础设施进行大量投资。

受生物技术进步和个人化医疗需求成长的推动，mRNA合成与生产市场正经历强劲成长。其中，合成环节占据主导地位，这主要得益于对高效且扩充性生产方法的需求。特别是，修饰核苷酸的合成因其能够增强mRNA的稳定性和翻译效率而主导关注。生产环节紧随其后，契约製造组织（CMO）透过提供专业服务和技术，市场份额不断扩大。疫苗研发子环节表现特别出色，主要得益于mRNA疫苗在对抗感染疾病的成功应用。治疗领域，特别是肿瘤和罕见疾病领域，表现排名第二，反映了标靶治疗的趋势。脂质奈米颗粒递送系统的创新也透过提高mRNA疗法的递送效率和疗效，推动了市场扩张。

市场区隔
类型 体外转录的mRNA、修饰的mRNA、未修饰的mRNA、自扩增的mRNA
产品 mRNA构建体、mRNA疫苗、mRNA疗法、mRNA递送系统
服务 客製化mRNA合成、mRNA优化、分析服务、品管和法规遵循支援。
科技 无细胞系统、酵素合成、化学合成、微流体系统
目的 感染疾病、癌症治疗、遗传性疾病、心血管疾病、罕见疾病
过程 上游工程、下游製程、配方、填充和成品。
最终用户 製药公司、生技公司、研究机构、契约製造组织
成分 营养物质、酵素、缓衝溶液、试剂
步 临床前、临床、商业化

市场概况：

mRNA合成与生产市场正经历市场份额、定价策略和产品创新方面的动态变化。老牌企业专注于透过价格竞争来提高市场渗透率，而新参与企业则推出创新产品以抓住新的机会。市场上拥有强大的产品平臺，专注于治疗应用。北美主导在技术进步和研发投入增加的推动下处于领先地位。同时，亚太地区正透过战略联盟和基础​​设施的扩张而获得发展动力。竞争格局以Moderna、BioNTech和CureVac等主要企业为特征，这些企业透过策略联盟和技术实力树立了行业标竿。北美和欧洲的法规结构是影响市场动态和合规标准的重要因素。合成生物学和个人化医疗的进步正在推动市场成长。然而，监管障碍和高昂的生产成本等挑战依然存在。儘管如此，持续的创新和策略伙伴关係正在为相关人员创造盈利机会。

主要趋势和驱动因素：

受多项关键趋势和驱动因素的推动，mRNA合成和生产市场正经历强劲成长。新冠疫苗的成功研发带动了对基于mRNA的疫苗和疗法的需求增长，这是主要驱动力，并促使企业投资于能够提高生产效率和扩充性的先进製造技术。一个显着的趋势是向自动化和数数位化製造流程的转变，这降低了生产成本并提高了精度。生技公司与学术机构之间加强合作以加速研发也是重要的市场趋势。政府资助和有利的法规结构进一步推动了市场扩张。此外，对个人化医疗的日益关注意味着mRNA技术在开发个人化疗法方面发挥着至关重要的作用。这种对个人化解决方案的关注正在推动mRNA合成技术的创新。随着这些趋势和驱动因素与不断变化的医疗保健需求和技术进步相契合，市场预计将继续保持成长势头。

压制与挑战：

mRNA合成和生产市场面临许多重大限制和挑战。其中一个主要挑战是生产流程的复杂性，这需要先进的技术和专业知识。这种复杂性通常会导致高昂的生产成本，限制了mRNA产品的扩充性和价格可负担性。监管障碍也是一项重大挑战。遵守严格的监管条件需要耗费大量时间和资源，从而延缓产品开发和市场准入。此外，原料供应链容易中断，对mRNA疗法的及时生产和分销产生负面影响。知识产权问题也加剧了市场的复杂性。市场的竞争性导致专利纠纷频繁，阻碍了创新和合作。此外，mRNA产品所需的低温运输物流增加了营运成本，并限制了基础设施不足地区的分销。最后，大众对mRNA技术的认知和误解也会影响市场接受度和需求。

目录

第一章：执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制因素
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章：细分市场分析

  • 市场规模及预测：依类型
    • mRNA的体外转录
    • 修饰的mRNA
    • 未修饰的mRNA
    • 自扩增mRNA
  • 市场规模及预测：依产品划分
    • mRNA构建体
    • 药效疫苗
    • mRNA治疗药物
    • mRNA递送系统
  • 市场规模及预测：依服务划分
    • 客製化mRNA合成
    • mRNA优化
    • 分析服务
    • 品管
    • 监管支持
  • 市场规模及预测：依技术划分
    • 无细胞系统
    • 酵素合成
    • 化学合成
    • 微流体系统
  • 市场规模及预测：依应用领域划分
    • 感染疾病
    • 癌症治疗
    • 遗传性疾病
    • 心血管疾病
    • 罕见疾病
  • 市场规模及预测：依製程划分
    • 上游工程
    • 下游工艺
    • 配方
    • 填充和表面处理工程
  • 市场规模及预测：依最终用户划分
    • 製药公司
    • 生技公司
    • 研究机构
    • 契约製造组织
  • 市场规模及预测：依组件划分
    • 核苷酸
    • 酵素
    • 缓衝
    • 试剂
  • 市场规模及预测：依阶段划分
    • 临床前阶段
    • 临床
    • 商业的

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 供需差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 监管概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • BioNTech
  • Moderna
  • CureVac
  • Translate Bio
  • Arcturus Therapeutics
  • Sangamo Therapeutics
  • eTheRNA Immunotherapies
  • Ethris
  • TriLink BioTechnologies
  • Aldevron
  • Ginkgo Bioworks
  • Senti Biosciences
  • Nutcracker Therapeutics
  • GreenLight Biosciences
  • Acuitas Therapeutics

第九章 关于我们

简介目录
Product Code: GIS34065

mRNA Synthesis and Manufacturing Market is anticipated to expand from $1.4 billion in 2024 to $8.2 billion by 2034, growing at a CAGR of approximately 19.3%. The mRNA Synthesis and Manufacturing Market encompasses the production of messenger RNA for therapeutic and vaccine applications. This market is driven by advancements in biotechnology, enabling rapid development and scalability of mRNA-based solutions. Key areas include synthesis technologies, purification processes, and quality control to ensure efficacy and safety. The rise in personalized medicine and infectious disease response is propelling market growth, with significant investments in research and infrastructure.

The mRNA Synthesis and Manufacturing Market is experiencing robust growth, spurred by advancements in biotechnology and increasing demand for personalized medicine. Within the market, the synthesis segment is leading, driven by the need for efficient and scalable production methods. The synthesis of modified nucleotides is particularly noteworthy, given its role in enhancing mRNA stability and translation efficiency. The manufacturing segment is not far behind, with contract manufacturing organizations (CMOs) gaining prominence due to their ability to offer specialized services and expertise. The vaccine development sub-segment stands out as a top performer, propelled by the success of mRNA vaccines in combating infectious diseases. Therapeutics, especially in oncology and rare diseases, represent the second highest performing sub-segment, reflecting a shift towards targeted treatments. Innovations in lipid nanoparticle delivery systems are also contributing to the market's expansion, as they improve the delivery and efficacy of mRNA-based therapies.

Market Segmentation
TypeIn vitro Transcription mRNA, Modified mRNA, Unmodified mRNA, Self-amplifying mRNA
ProductmRNA Constructs, mRNA Vaccines, mRNA Therapeutics, mRNA Delivery Systems
ServicesCustom mRNA Synthesis, mRNA Optimization, Analytical Services, Quality Control, Regulatory Support
TechnologyCell-free Systems, Enzymatic Synthesis, Chemical Synthesis, Microfluidic Systems
ApplicationInfectious Diseases, Cancer Treatment, Genetic Disorders, Cardiovascular Diseases, Rare Diseases
ProcessUpstream Processing, Downstream Processing, Formulation, Fill and Finish
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations
ComponentNucleotides, Enzymes, Buffers, Reagents
StagePreclinical, Clinical, Commercial

Market Snapshot:

The mRNA Synthesis and Manufacturing Market is experiencing dynamic shifts in market share, pricing strategies, and product innovations. Established companies are focusing on competitive pricing to enhance market penetration, while new entrants are launching innovative products to capture emerging opportunities. The market is witnessing a robust pipeline of products, with a strong emphasis on therapeutic applications. North America dominates the landscape, driven by technological advancements and increased R&D investments. Meanwhile, the Asia-Pacific region is gaining momentum, fueled by strategic collaborations and expanding infrastructure. The competitive landscape is characterized by key players such as Moderna, BioNTech, and CureVac, who are setting industry benchmarks through strategic alliances and technological prowess. Regulatory frameworks in North America and Europe are pivotal, influencing market dynamics and compliance standards. The market is poised for growth, driven by advancements in synthetic biology and personalized medicine. However, challenges like regulatory hurdles and high production costs persist. Nonetheless, the ongoing innovation and strategic partnerships present lucrative opportunities for stakeholders.

Geographical Overview:

The mRNA synthesis and manufacturing market is witnessing robust growth across several regions, each presenting unique opportunities. North America is at the forefront, propelled by significant advancements in biotechnology and substantial investments in research and development. The presence of key industry players and a supportive regulatory framework further enhances the market's potential. Europe follows closely, with a strong focus on innovation and sustainable healthcare solutions. Government initiatives and funding for biopharmaceutical research are catalyzing market expansion. The region's commitment to cutting-edge medical research is fostering a conducive environment for mRNA technologies. In the Asia Pacific, the market is expanding rapidly, driven by technological advancements and increasing healthcare demands. Countries like China and India are emerging as pivotal growth pockets due to their vast population bases and growing investments in biotechnology. Latin America and the Middle East & Africa are also showing promising potential, with rising awareness and investments in mRNA technologies fueling market growth.

Key Trends and Drivers:

The mRNA synthesis and manufacturing market is experiencing robust growth due to several key trends and drivers. The increasing demand for mRNA-based vaccines and therapeutics is a primary driver, fueled by the success of COVID-19 vaccines. This demand is spurring investments in advanced manufacturing technologies to enhance production efficiency and scalability. A notable trend is the shift towards automated and digitalized manufacturing processes. These advancements are reducing production costs and improving precision. The market is also witnessing increased collaboration between biotech companies and academic institutions to accelerate research and development efforts. Government support through funding and favorable regulatory frameworks is further propelling market expansion. Moreover, there is a growing emphasis on personalized medicine, where mRNA technology plays a crucial role in developing tailored treatments. This focus on personalized solutions is driving innovation in mRNA synthesis. The market is poised for continued growth as these trends and drivers align with evolving healthcare needs and technological advancements.

Restraints and Challenges:

The mRNA Synthesis and Manufacturing Market faces several significant restraints and challenges. A primary challenge is the complexity of manufacturing processes, which requires advanced technology and specialized expertise. This complexity often leads to high production costs, limiting the scalability and affordability of mRNA-based products. Regulatory hurdles also pose a significant challenge. Navigating the stringent regulatory landscape requires substantial time and resources, delaying product development and market entry. Furthermore, the supply chain for raw materials is vulnerable to disruptions, impacting the timely production and distribution of mRNA therapeutics. Intellectual property issues add another layer of complexity. The competitive nature of the market leads to frequent patent disputes, hindering innovation and collaboration. Additionally, the need for cold chain logistics for mRNA products increases operational costs and limits distribution in regions with inadequate infrastructure. Lastly, public perception and misinformation about mRNA technology can affect market acceptance and demand.

Key Players:

BioNTech, Moderna, CureVac, Translate Bio, Arcturus Therapeutics, Sangamo Therapeutics, eTheRNA Immunotherapies, Ethris, TriLink BioTechnologies, Aldevron, Ginkgo Bioworks, Senti Biosciences, Nutcracker Therapeutics, GreenLight Biosciences, Acuitas Therapeutics

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Process
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Component
  • 2.9 Key Market Highlights by Stage

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 In vitro Transcription mRNA
    • 4.1.2 Modified mRNA
    • 4.1.3 Unmodified mRNA
    • 4.1.4 Self-amplifying mRNA
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 mRNA Constructs
    • 4.2.2 mRNA Vaccines
    • 4.2.3 mRNA Therapeutics
    • 4.2.4 mRNA Delivery Systems
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Custom mRNA Synthesis
    • 4.3.2 mRNA Optimization
    • 4.3.3 Analytical Services
    • 4.3.4 Quality Control
    • 4.3.5 Regulatory Support
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Cell-free Systems
    • 4.4.2 Enzymatic Synthesis
    • 4.4.3 Chemical Synthesis
    • 4.4.4 Microfluidic Systems
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Infectious Diseases
    • 4.5.2 Cancer Treatment
    • 4.5.3 Genetic Disorders
    • 4.5.4 Cardiovascular Diseases
    • 4.5.5 Rare Diseases
  • 4.6 Market Size & Forecast by Process (2020-2035)
    • 4.6.1 Upstream Processing
    • 4.6.2 Downstream Processing
    • 4.6.3 Formulation
    • 4.6.4 Fill and Finish
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Pharmaceutical Companies
    • 4.7.2 Biotechnology Companies
    • 4.7.3 Research Institutes
    • 4.7.4 Contract Manufacturing Organizations
  • 4.8 Market Size & Forecast by Component (2020-2035)
    • 4.8.1 Nucleotides
    • 4.8.2 Enzymes
    • 4.8.3 Buffers
    • 4.8.4 Reagents
  • 4.9 Market Size & Forecast by Stage (2020-2035)
    • 4.9.1 Preclinical
    • 4.9.2 Clinical
    • 4.9.3 Commercial

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Process
      • 5.2.1.7 End User
      • 5.2.1.8 Component
      • 5.2.1.9 Stage
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Process
      • 5.2.2.7 End User
      • 5.2.2.8 Component
      • 5.2.2.9 Stage
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Process
      • 5.2.3.7 End User
      • 5.2.3.8 Component
      • 5.2.3.9 Stage
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Process
      • 5.3.1.7 End User
      • 5.3.1.8 Component
      • 5.3.1.9 Stage
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Process
      • 5.3.2.7 End User
      • 5.3.2.8 Component
      • 5.3.2.9 Stage
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Process
      • 5.3.3.7 End User
      • 5.3.3.8 Component
      • 5.3.3.9 Stage
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Process
      • 5.4.1.7 End User
      • 5.4.1.8 Component
      • 5.4.1.9 Stage
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Process
      • 5.4.2.7 End User
      • 5.4.2.8 Component
      • 5.4.2.9 Stage
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Process
      • 5.4.3.7 End User
      • 5.4.3.8 Component
      • 5.4.3.9 Stage
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Process
      • 5.4.4.7 End User
      • 5.4.4.8 Component
      • 5.4.4.9 Stage
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Process
      • 5.4.5.7 End User
      • 5.4.5.8 Component
      • 5.4.5.9 Stage
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Process
      • 5.4.6.7 End User
      • 5.4.6.8 Component
      • 5.4.6.9 Stage
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Process
      • 5.4.7.7 End User
      • 5.4.7.8 Component
      • 5.4.7.9 Stage
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Process
      • 5.5.1.7 End User
      • 5.5.1.8 Component
      • 5.5.1.9 Stage
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Process
      • 5.5.2.7 End User
      • 5.5.2.8 Component
      • 5.5.2.9 Stage
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Process
      • 5.5.3.7 End User
      • 5.5.3.8 Component
      • 5.5.3.9 Stage
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Process
      • 5.5.4.7 End User
      • 5.5.4.8 Component
      • 5.5.4.9 Stage
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Process
      • 5.5.5.7 End User
      • 5.5.5.8 Component
      • 5.5.5.9 Stage
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Process
      • 5.5.6.7 End User
      • 5.5.6.8 Component
      • 5.5.6.9 Stage
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Process
      • 5.6.1.7 End User
      • 5.6.1.8 Component
      • 5.6.1.9 Stage
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Process
      • 5.6.2.7 End User
      • 5.6.2.8 Component
      • 5.6.2.9 Stage
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Process
      • 5.6.3.7 End User
      • 5.6.3.8 Component
      • 5.6.3.9 Stage
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Process
      • 5.6.4.7 End User
      • 5.6.4.8 Component
      • 5.6.4.9 Stage
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Process
      • 5.6.5.7 End User
      • 5.6.5.8 Component
      • 5.6.5.9 Stage

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 BioNTech
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Moderna
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 CureVac
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Translate Bio
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Arcturus Therapeutics
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Sangamo Therapeutics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 eTheRNA Immunotherapies
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Ethris
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 TriLink BioTechnologies
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Aldevron
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Ginkgo Bioworks
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Senti Biosciences
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Nutcracker Therapeutics
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 GreenLight Biosciences
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Acuitas Therapeutics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us